These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
8. Application of liver-specific contrast agents for evaluation of focal liver lesions - Expert recommendations from the Gastrointestinal and Abdominal Imaging Workgroup of the German Roentgen Society. Ringe KI; Fischbach F; Grenacher L; Juchems MS; Kukuk G; Lauenstein T; Wessling J; Schreyer AG Rofo; 2024 Jul; 196(7):690-698. PubMed ID: 38113896 [No Abstract] [Full Text] [Related]
9. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue]. Hohmann J; Skrok J; Puls R; Albrecht T Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698 [TBL] [Abstract][Full Text] [Related]
10. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. Burke C; Alexander Grant L; Goh V; Griffin N Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317 [TBL] [Abstract][Full Text] [Related]
11. Non-focal liver signal abnormalities on hepatobiliary phase of gadoxetate disodium-enhanced MR imaging: a review and differential diagnosis. Furlan A; Borhani AA; Heller MT; Yu RK; Tublin ME Abdom Radiol (NY); 2016 Jul; 41(7):1399-410. PubMed ID: 26907715 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the link between quantitative biexponential diffusion-weighted imaging and contrast-enhanced MRI in the liver. Dijkstra H; Oudkerk M; Kappert P; Sijens PE Magn Reson Imaging; 2017 May; 38():47-53. PubMed ID: 27993534 [TBL] [Abstract][Full Text] [Related]
13. Diffusion and perfusion imaging of the liver. Chandarana H; Taouli B Eur J Radiol; 2010 Dec; 76(3):348-58. PubMed ID: 20399054 [TBL] [Abstract][Full Text] [Related]
14. MR-IMAGING IN DIAGNOSTICS OF FOCAL LIVER LESIONS. Bagnenko SS; Trufanov GE; Zheleznyak IS Vestn Khir Im I I Grek; 2016; 175(3):68-72. PubMed ID: 30444097 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a respiratory navigator-gating technique in Gd-EOB-DTPA-enhanced magnetic resonance imaging for the assessment of liver tumors. Ogasawara G; Inoue Y; Matsunaga K; Fujii K; Hata H; Miyatake H; Iwadate Y Eur J Radiol; 2016 Jun; 85(6):1232-7. PubMed ID: 27161075 [TBL] [Abstract][Full Text] [Related]
16. Focal masses in a non-cirrhotic liver: The additional benefit of CEUS over baseline imaging. Chiorean L; Cantisani V; Jenssen C; Sidhu PS; Baum U; Dietrich CF Eur J Radiol; 2015 Sep; 84(9):1636-43. PubMed ID: 26049958 [TBL] [Abstract][Full Text] [Related]
17. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents]. Ba-Ssalamah A; Happel B; Kettenbach J; Dirisamer A; Wrba F; Längle F; Schima W Radiologe; 2004 Dec; 44(12):1170-84. PubMed ID: 15551031 [TBL] [Abstract][Full Text] [Related]
18. Contrast-Enhanced Ultrasound of Focal Liver Lesions. Chaubal N; Joshi M; Bam A; Chaubal R Semin Roentgenol; 2016 Oct; 51(4):334-357. PubMed ID: 27743569 [No Abstract] [Full Text] [Related]
19. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F; J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of the pediatric liver: benign and malignant masses. Keup CP; Ratnaraj F; Chopra PR; Lawrence CA; Lowe LH Magn Reson Imaging Clin N Am; 2013 Nov; 21(4):645-67. PubMed ID: 24183518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]